Skip to content
Govbase
Govbase
← All efforts
Active in CongressEffort

Allow patients with Alpha-1 antitrypsin deficiency to receive their prescribed medication infusions at home.

One policy goal, tracked across every bill that has carried it.

Known asJohn W. Walsh Alpha-1 Home Infusion Act of 2025

What’s happening with John W. Walsh Alpha-1 Home Infusion Act of 2025?

The John W. Walsh Alpha-1 Home Infusion Act of 2025, known as H.R. 2343, has remained in the House Energy and Commerce and Ways and Means committees since March 24, 2025. Members of these committees must hold a vote to move the bill forward, but most legislation fails to receive a committee vote and dies through inaction. This bill has seen no recorded progress for 15 months as of June 2026.

Updated July 9, 2026 · Generated by AI. Always verify with official sources.

Where it stands

Now carried by John W. Walsh Alpha-1 Home Infusion Act of 2025 (H.R. 2343 (119th)) →

Legislative Progress

House
Senate
President
Law

Next up: A house committee · Nothing moves until they act.

How we got here

Every bill that has carried this goal, oldest first.

  1. Died with Congress · Jan 3, 2025

    Died when the 118th Congress ended without final passage. Bills must be reintroduced under a new number to be revived.

  2. Reintroduced · Jan 3, 2025

    Reintroduced from H.R. 4438 (118th), which died when its Congress ended.

    H.R. 4438 (118th)

Vehicles

Who’s behind it

Maria Salazar (R-FL)Wrote and sponsored the current bill.